Many pressing medical challenges -such as diagnosing disease, enhancing directed stem cell differentiation, and classifying cancers -have long been hindered by limitations in our ability to quantify proteins in single cells. Mass-spectrometry (MS) is poised to transcend these limitations by developing powerful methods to routinely quantify thousands of proteins and proteoforms across many thousands of single cells. We outline specific technological developments and ideas that can increase the sensitivity and throughput of single cell MS by orders of magnitude and usher in this new age. These advances will transform medicine and ultimately contribute to understanding biological systems on an entirely new level. However, many pressing needs in medicine, such as diagnosing disease and enhancing directed stem cell differentiation, as well as transformative opportunities in biology, demand qualifying 100 − 1000 fold more proteins; they demand an entirely different set of approaches and techniques. Such approaches are beginning to coalesce around new ideas and emerging technologies in MS-based proteomics that promise quantifying thousands of proteins and all their modifications (termed proteoforms) across thousands of single mammalian cells. We begin by outlining the urgent demand and exciting opportunities for these methods since this context can best motivate future methodological developments. Then we discuss specific technical opportunities that can increase the sensitivity and throughput of single cell proteomics by orders of magnitude and thus contribute to realizing its tremendous promise.
Limitations of population-average measurements
The ability to quantify nearly complete transcriptomes and proteomes from bulk samples has been transformative for biomedical research [9] [10] [11] . It has enabled unbiased screens and unexpected discoveries [12] [13] [14] . Yet comprehensive proteome measurements have been confined to samples comprised of many cells, reflecting only the population-average. Interpreting population-average protein levels is fundamentally confounded when samples consist of heterogeneous cells. The most obvious caveat is that the population-average may not be representative for any cell. For example, proteoforms may have bimodally-distributed abundances within the whole heterogenous cell population.
More generally, trends within groups -within different cell types, for instance -may disappear or even reverse when these groups are combined, as with population-average measurements. This phenomenon is known as Simpson's paradox 15 . We recently demonstrated 16 the confounding effects of Simpson's paradox in using mRNA levels as surrogates for protein levels with bulk data, 
Single-cell proteomics opens exciting frontiers
Single cell proteomics will allow us to perform causal protein inference and create unbiased models of direct and indirect protein interactions. These exciting prospects require estimating joint and conditional probability distributions of proteins across single cells, which in turn require many mRNA measurements (a) For a particular gene, its protein levels across tissues can be poorly predicted by its mRNA levels, while the average protein levels can be well predicted by scaled mRNA levels 16 . Thus mRNAs levels are unreliable surrogates for relative protein levels, and we need direct measurements of proteins. (b) A related manifestation of Simpson's paradox indicates that the average levels of the i th and the j th proteins may appear positively correlated, even though they are inversely correlated within a cell-type. Averaging across cells, even cell types sorted based on markers, will obscure the the relationship between the i th and the j th proteins.
teins. Reliably-estimated joint distributions of proteoforms enable modeling protein-protein dependencies with the empirical probabilities, without assuming a sigmoidal, linear, or any specific relationship. Such models can infer the dependence and its causality between any two measured proteoforms while controlling -without assumptions -for the influence of all other measured
proteoforms. Yet, these models can control only for the measured proteins. Thus, the full power of such analysis, which can lead to causal inference, requires measuring all relevant proteoforms.
We believe that high-throughput single-cell proteomics can estimate the joint distributions among the relevant proteforms, and in the process catalyze a transition from the population-average measurements to casual inference, elucidating direct and indirect protein interactions and signaling mechanism. Similarly, the joint distributions enable estimating the mutual information (MI) between proteins. The MI inequality states that the mutual information between a variable X, e.g., a kinase, and its causal variable, e.g., an upstream kinase, is always larger than the mutual information between X and another correlated but not causal variable. This allows us to determine which protein kinases are upstream and downstream in a signaling cascade, or another similar biological sequence of causal events. Such progress will produce models that can predict and design the outcomes of new treatments, e.g, rationally engineer directed differentiation of stem cells into cell types of interest. Realizing these promises requires increasing both the sensitivity and the through-put of of single-cell proteomics. We believe both factors can be increased by orders of magnitude based on the suggestions outlines below.
Transformative opportunities for realizing single cell proteomics that exceed the size of a typical mammalian cell (∼ 15µm diameter) by orders of magnitude 20 .
Protein measurements in typical mammalian cells have quantified thousands of proteins in cell lysates corresponding to hundreds of cells 21 , and just recently we reported a method that allows quantifying over a thousand proteins across many single mouse stem cells 17 . We believe that the field is ready to take off from this launching point, and increase the number of accurately-quantified proteins and the number of single cells assayed by orders of magnitude.
The relatively high copy number of proteins per cell 20 can support both deep proteome quantification and low sampling error compared to single cell RNA-seq. So far, RNA-seq has quantified the most molecules per cell but the accuracy of these measurements has been limited by counting noise: since only a subset of the RNA molecules are sampled (counted), their estimated abundances contain missing values and counting error due to sampling 22 . If we count n molecules out of a larger pool, the Poisson distribution estimates the standard deviation of the sampling as √ n, and thus the relative error, estimated as standard deviation over mean, is √ n/n = 1/ √ n.
Therefore, if we sample 20% of the mRNA molecules from a relatively abundant gene and obtain 4 sequences per cell, we can expect about 1/ √ 4 = 50% relative error from the sampling alone. Since cells contain over a 1000 protein molecules per mRNA molecule 20 , the counting error of protein sampling is likely to be smaller: For the median protein, having 50, 000 molecules per cell, sampling even 1% of the molecules will result in about 1/ √ 500 ≈ 5% sampling error.
These numbers promise deep and accurate quantification of single-cell proteomics if we can accomplish the opportunities discussed below. The challenges are technical -posing no conceptual limitations -and we believe they are tractable with current and emerging ideas and technologies.
Many of these challenges and opportunities are similar for bottom-up methods (measuring peptides after protease digestion) and for top-down methods (measuring undigested proteins) and we discuss them together, although top-down proteomics faces lower sensitivity, harder multiplexing and more challenging protein identification.
Sample preparation
Cell extraction and separation for single cell proteomics can be similar to cell extraction for other analytical methods, i.e., single cell RNA-seq, and such methods have been reviewed extensively 23 .
After extraction and separation, sample preparation for single cell proteomics should ideally result in complete cell lysis and digestion, incur minimal loss of protein, and allow high-throughput automation for the analysis of thousands, even millions, of single cells. Standard MS sample preparation methods use 10 − 100 µl volumes; reducing these volumes to 1 µl or less will afford a substantial reduction in protein loss and reagents used, Fig. 2a . This protein loss is primarily due to surface adsorption, which bulk proteomics overcomes by operating near the protein or peptide solubility limit. To mimic that approach for single cell proteomics, given the ∼ 500 pg of protein in a typical mammalian cell 20 , the reaction volume should be limited to nanoliters. While techniques for surface passivation permit that volume to expand, automated precision liquid handling will play a large role in single cell proteomics, making sample preparation robust, high-throughput, and cost-effective at scale. Furthermore, cell lysis methods that use only MS-compatible reagents, e.g., sonication in water 17, 21 , can obviate cleanup and further reduce losses. Such approaches can increase sensitivity and throughput by orders of magnitude, Fig. 2a,d .
Peptide separation
Modern MS methods sample only a fraction of each elution peak, which corresponds to 1% or less of the ions for each peptide that the instrument could sample (Fig. 2b) . This small fraction is (Fig. 2e) . Alternatively, parallel accumulation and serial injection can be achieved by trapped ion mobility spectrometry 24 . For long accumulation times, and thus sensitive MS, the increase in throughout by parallel accumulation is proportional to the number of ions accumulated in parallel, and we expect to gain 2 − 10 fold, Fig. 2e .
Higher-multiplexing for increased throughput
Achieving high chromatographic resolution and quantifying 1000s of proteins requires an hour of LC-MS/MS time or more. Thus, to quantify the proteomes of thousands of single cells within hours, we need to quantify many cells per LC-MS/MS run. Such multiplexing can be achieved by isobaric chemical barcoding 25 . These barcodes are chemically identical, but distinguishable by MS due to their different isotopic compositions. While there are a number of commercially-available barcodes sets, the largest such set only allows the simultaneous analysis of eleven different samples. However, larger sets of barcodes can be synthesized and indeed many colleagues are actively working on making multiplex tags that would allow 30 − 100 individual cells to be measured in parallel (Fig. 2f) . In creating new barcodes for single cell proteomics, there is an opportunity to solve an outstanding problem with the technology, coisolation: quantitative fragments from the currently-available barcodes are not peptide specific, allowing the signal to be polluted by fragments from different peptide species 26 . The barcode labeling chemistry would have to be changed such that the barcode to peptide bond is much stronger or the barcodes require less energy for fragmentation, allowing the quantification to be based on peptide-specific complement ions.
Protein identification and data analysis
While the analysis of single cell MS data can use tools developed for bulk MS, it raises specific challenges and opportunities. One specific challenge is peptide sequencing. At very low abundance, many peptides may not produce enough fragment ions to support confident identification.
One solution may be to include a carrier channel together with single-cells, each of which labeled with a unique tandem-mass-tag 17 . With this strategy, the fragment ions supporting peptide identification are derived from peptides pooled across all samples, including the carrier channel 17 .
Combining this strategy with further increases in the number of distinct tandem-mass-tags will further facilitate peptide identification and decrease the need for carrier cells. Another approach is to use additional peptides characteristics, such as retention time or empirical spectra. These approaches can exploit the fact that single cell proteomics data will contain multiple similar runs that can be used, for example, for making spectral libraries. As we discussed already, quantifying 1000s of single cells in a reasonable time frame requires barcoding, which will benefit from new computational approaches to accurately merge quantitative data sets acquired separately. If single cell proteomes are quantified by shotgun MS, the proteins quantified in different runs will overlap partially, with some proteins quantified across all MS runs, while others only in a subset of the runs. This partial overlap will result in missing data, i.e., the levels of some proteins will not be quantified in some single cells. Such missing data are pervasive with respect to single cell RNA-seq 22 , and must be handled carefully in single cell proteomics to avoid artifacts.
